X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ASTRAZENECA PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ASTRAZENECA PHARMA ALEMBIC LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 122.8 104.6 117.4% View Chart
P/BV x 4.6 14.9 30.6% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 ALEMBIC LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ASTRAZENECA PHARMA
Mar-14
ALEMBIC LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs531,285 4.1%   
Low Rs29634 4.6%   
Sales per share (Unadj.) Rs4.7189.6 2.5%  
Earnings per share (Unadj.) Rs8.8-0.2 -4,309.2%  
Cash flow per share (Unadj.) Rs9.03.8 234.2%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.768.6 40.4%  
Shares outstanding (eoy) m267.0325.00 1,068.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.75.1 171.9%   
Avg P/E ratio x4.7-4,712.7 -0.1%  
P/CF ratio (eoy) x4.6249.6 1.8%  
Price / Book Value ratio x1.514.0 10.6%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,96223,988 45.7%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m2381,605 14.8%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m1,2604,740 26.6%  
Other income Rs m26492 286.4%   
Total revenues Rs m1,5244,832 31.5%   
Gross profit Rs m83-130 -63.8%  
Depreciation Rs m61101 60.7%   
Interest Rs m00-   
Profit before tax Rs m285-139 -205.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32139 -23.2%   
Tax Rs m65 119.8%   
Profit after tax Rs m2,343-5 -46,027.5%  
Gross profit margin %6.6-2.7 -239.9%  
Effective tax rate %2.1-3.7 -58.4%   
Net profit margin %185.9-0.1 -173,099.3%  
BALANCE SHEET DATA
Current assets Rs m1,6892,726 61.9%   
Current liabilities Rs m4862,435 20.0%   
Net working cap to sales %95.46.1 1,552.1%  
Current ratio x3.51.1 310.2%  
Inventory Days Days21774 294.2%  
Debtors Days Days8141 198.8%  
Net fixed assets Rs m1,6241,035 156.9%   
Share capital Rs m53450 1,068.2%   
"Free" reserves Rs m5,960942 632.4%   
Net worth Rs m7,4041,716 431.5%   
Long term debt Rs m1040-   
Total assets Rs m8,0104,156 192.7%  
Interest coverage x950.7NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.21.1 13.8%   
Return on assets %29.3-0.1 -23,883.6%  
Return on equity %31.6-0.3 -10,667.8%  
Return on capital %31.30-  
Exports to sales %2.95.7 51.6%   
Imports to sales %28.96.5 446.5%   
Exports (fob) Rs m37270 13.7%   
Imports (cif) Rs m364306 118.7%   
Fx inflow Rs m37375 9.9%   
Fx outflow Rs m365470 77.6%   
Net fx Rs m-328-96 343.1%   
CASH FLOW
From Operations Rs m346-8 -4,266.7%  
From Investments Rs m-48-146 32.7%  
From Financial Activity Rs m-301862 -34.9%  
Net Cashflow Rs m-3709 -0.4%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.2 0.3 66.7%  
FIIs % 9.7 15.7 61.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 9.1 286.8%  
Shareholders   54,701 12,856 425.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   AJANTA PHARMA  GLENMARK PHARMA  SHASUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 23, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS